Band-Aid Maker Kenvue Cuts Workforce By 4%, Q1 Earnings Beat Street Expectations
Band-Aid Maker Kenvue Cuts Workforce By 4%, Q1 Earnings Beat Street Expectations
Pure-play consumer health company Kenvue Inc (NYSE:KVUE) reported first-quarter sales of $3.89 billion, beating the consensus of $3.79 billion.
Pure-Play消费者健康公司Kenvue Inc（纽约证券交易所代码：KVUE）报告称，第一季度销售额为38.9亿美元，超过市场预期的37.9亿美元。
Kenvue's some of the iconic brands include Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, and Tylenol.
Kenvue的一些标志性品牌包括Aveeno、BAND-AID Brand、强生、利斯特林、露得清和泰诺。
Sales increased 1.1%, up from 7.3% in the prior year period. Organic growth was 1.9%, up from 11.2% in the prior year.
销售额增长了1.1％，高于去年同期的7.3％。有机增长率为1.9％，高于去年的11.2％。
Increases in net sales and organic growth were primarily driven by sustained momentum in Self Care on strong consumer demand and growth in Essential Health led by Oral Care, partially offset by underperformance in Skin Health and Beauty.
净销售额的增长和有机增长主要是由强劲的消费者需求和以口腔护理为首的Essential Health的持续增长推动的Self Care的持续增长势头，但皮肤健康与美容的表现不佳部分抵消了增长。
Net sales and organic growth comprised +5.0% value realization and (3.1%) volume.
净销售额和有机增长包括 +5.0% 的价值实现率和（3.1%）的销量。
The self-care segment recorded $1.70 billion in net sales, up 3.5% year over year, with the skin health and beauty segment recording a 5% drop in first-quarter net sales to $1.05 billion. Essential Health segment sales increased around 4% to $1.14 billion.
自我保健板块净销售额为17.0亿美元，同比增长3.5％，皮肤健康和美容板块第一季度净销售额下降5％，至10.5亿美元。基本健康板块的销售额增长了约4％，达到11.4亿美元。
The company reported adjusted EPS of $0.28, down from $0.37 a year ago, beating the consensus of $0.26.
该公司报告调整后的每股收益为0.28美元，低于去年同期的0.37美元，超过了市场预期的0.26美元。
Kenvue will reduce its current global workforce by approximately 4% and targets annualized pre-tax gross cost savings of approximately $350 million by 2026.
Kenvue将裁减其目前的全球员工队伍约4％，目标是到2026年每年节省约3.5亿美元的税前总成本。
The company expects to incur approximately $275 million of pre-tax restructuring costs in fiscal year 2024 and fiscal year 2025.
该公司预计在2024财年和2025财年将产生约2.75亿美元的税前重组成本。
The first quarter adjusted gross profit margin was 60.2% vs. 57.3% in the prior year. Margin expansion of 290 basis points was primarily driven by value realization, continued global supply chain efficiency initiatives, and easing net input cost inflation.
第一季度调整后的毛利率为60.2％，去年同期为57.3％。290个基点的利润增长主要是由价值实现、持续的全球供应链效率举措以及净投入成本通胀的缓解所推动的。
The adjusted operating income margin was 22.0% vs. 21.3% in the prior year.
调整后的营业收入利润率为22.0％，去年同期为21.3％。
Guidance: Kenvue expects full-year 2024 reported net sales growth of 1.0%- 3.0%, with organic growth of 2.0% to 4.0%.
指导方针：Kenvue预计，2024年全年报告的净销售额增长1.0％至3.0％，有机增长2.0％至4.0％。
Kenvue expects full-year 2024 adjusted EPS of $1.10-$1.20 versus consensus of $1.15.
Kenvue预计，2024年全年调整后的每股收益为1.10美元至1.20美元，而市场普遍预期为1.15美元。
Price Action: KVUE shares are up 4.95% at $20.03 at last check Tuesday.
价格走势：在周二的最后一次检查中，KVUE股价上涨4.95％，至20.03美元。
Photo by Colleen Michaels via Shutterstock
照片由 Colleen Michaels 通过 Shutterstock 拍摄